Testing effectiveness (Phase 2)Study completedNCT01323400What this trial is testingEfficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)Who this might be right forGIST Centre Leon Berard 81
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Study completedNCT04995419What this trial is testingEvaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor TherapyWho this might be right forMetastatic Urothelial Cancer Astellas Pharma China, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00416767What this trial is testingCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Large-scale testing (Phase 3)Looking for participantsNCT07071337What this trial is testingSKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine TherapyWho this might be right forMetastatic Breast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Study completedNCT00068211What this trial is testingStudy of ILX651 in Patients With Inoperable Locally Advanced or Metastatic MelanomaWho this might be right forMelanoma Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT05075564What this trial is testingES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumor Elpiscience Biopharma, Ltd. 8
Testing effectiveness (Phase 2)Looking for participantsNCT02029001What this trial is testingAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentWho this might be right forMalignant Solid Neoplasms Centre Leon Berard 900
Early research (Phase 1)Study completedNCT01189929What this trial is testingGemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer OncoMed Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)Study completedNCT00551421What this trial is testingPertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Looking for participantsNCT06899126What this trial is testingStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Daiichi Sankyo 686
Testing effectiveness (Phase 2)Study completedNCT05219435What this trial is testingStudy of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial CancerWho this might be right forUrothelial Cancer Spanish Oncology Genito-Urinary Group 25
Testing effectiveness (Phase 2)Study completedNCT03406299What this trial is testingPhase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerWho this might be right forBiliary Tract Neoplasms National Health Research Institutes, Taiwan 92
Testing effectiveness (Phase 2)Study completedNCT03104699What this trial is testingAGEN2034 in Advanced Tumors and Cervical CancerWho this might be right forAdvanced CancerCervical Cancer Agenus Inc. 211
Testing effectiveness (Phase 2)Active Not RecruitingNCT05668858What this trial is testingSI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of Head and Neck Sichuan Baili Pharmaceutical Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT02114658What this trial is testingSorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsWho this might be right forThyroid Carcinoma Bayer 18
Early research (Phase 1)Study completedNCT03307148What this trial is testingStromal TARgeting for PAncreatic Cancer (STAR_PAC)Who this might be right forPancreatic Adenocarcinoma Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Ended earlyNCT03184558What this trial is testingBemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBCWho this might be right forTriple Negative Breast CancerInflammatory Breast Cancer Stage IV BerGenBio ASA 29
Large-scale testing (Phase 3)UnknownNCT03538171What this trial is testingPh3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast CancerWho this might be right forAdvanced Breast Cancer Taizhou EOC Pharma Co., Ltd. 375